Experience

Sirius Therapeutics Announces Collaboration With CRISPR Therapeutics

May 19, 2025

Cooley advised Sirius Therapeutics, a clinical-stage biotech company developing innovative small interfering RNA (siRNA) therapies for global markets, on its strategic partnership to develop and commercialize siRNA therapies with CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Navya Dasari
Associate, New York
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Santa Monica
Steve Przesmicki
Partner, San Diego
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
David Burns
Special Counsel, Washington, DC
Eileen Marshall
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado

Related Practices & Industries

Jiangsu Hengrui Pharmaceuticals Announces License Agreement With Merck

March 25, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck (NYSE: MRK), known as MSD outside of the US and Canada, for HRS-5346, an investigational oral small molecule lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a phase 2 clinical trial in China.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
David Burns
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Steve Przesmicki
Partner, San Diego

Related Practices & Industries

Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck

October 14, 2024

Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.

Read more

Related contacts

Kevin Cooper
Partner, New York
Steve Przesmicki
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
David Burns
Special Counsel, Washington, DC
Jenny Ge
Associate, Santa Monica
Jeewon Lee
Associate, New York
Charity Williams
Partner, San Diego
Son Nguyen
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Cara Buchicchio
Associate, New York
Jameson Davis
Associate, Boston
Sela Dougherty
Associate, Miami
Rubin Waranch
Associate, Colorado

Related Practices & Industries

AGS Announces Definitive Agreement to Be Acquired by Brightstar Capital Partners for $1.1 Billion

May 9, 2024

Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Steve Przesmicki
Partner, San Diego
David Silverman
Partner, New York
Natalie D. Vernon
Associate, Colorado
Rachel Shapiro
Associate, Colorado
Barbara Mirza
Partner, Santa Monica
Alexander Ellebracht
Associate, Palo Alto
Alexandra Leavy
Associate, New York
Peter Adams
Partner, San Diego
Megan Browdie
Partner, Washington, DC
Thomas Connors
Partner, Boston
Kevin Cooper
Partner, New York
Ross Eberly
Partner, Santa Monica
Patrick Flanagan
Partner, New York
Todd Gluth
Partner, San Diego
Christine Graham
Special Counsel, London
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Alexis Guillermo Buz
Associate, San Diego
James Christopher
Associate, Boston
Joshua Elefant
Associate, Palo Alto
Jimmy Gilligan
Associate, Boston
Katie Kaufman
Associate, Boston
Allison Kutner
Associate, New York
Kyrsten Lundh
Associate, San Diego
Sangitha Palaniappa
Associate, Palo Alto
María Álvarez Requejo Heredero
Associate, Brussels
Sarah Buchik
Associate, New York

Related Practices & Industries

Seven and Eight Biopharma Announces Global License, Collaboration Agreement With Eikon

June 14, 2023

Cooley advised Seven and Eight Biopharmaceuticals, clinical-stage biotechnology company focused on the development and commercialization of novel immunotherapies for cancer, on its license and collaboration agreement with Eikon Therapeutics, a biotechnology company.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Steve Przesmicki
Partner, San Diego
Bin Wang
Special Counsel, Palo Alto
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

California

Wisconsin

Rankings and accolades

Best Lawyers in America: Corporate Law

San Diego Super Lawyers

Southern California Super Lawyers